Approval · Notice of Compliance 4922 · 1995
SUPRAX: Notice of Compliance 4922
Issued November 29, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4922
- Date
- November 29, 1995
- Company
- Rhone-Poulenc Rorer Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic